home / stock / ofix / ofix news


OFIX News and Press, Orthofix Medical Inc. From 06/20/23

Stock Information

Company Name: Orthofix Medical Inc.
Stock Symbol: OFIX
Market: NASDAQ
Website: orthofix.com

Menu

OFIX OFIX Quote OFIX Short OFIX News OFIX Articles OFIX Message Board
Get OFIX Alerts

News, Short Squeeze, Breakout and More Instantly...

OFIX - Orthofix Announces Changes to Board of Directors

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik has been re-appointed as the Chair of the Company’s Board of Directors. Additionally, shareholders re-elected Wayne Burris who previously served on the Orthofix boar...

OFIX - Orthofix Announces the Full Commercial Launch of WaveForm A 3D Printed Anterior Lumbar Interbody

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of the WaveForm ® A interbody for Anterior Lumbar Interbody Fusion (ALIF) procedures. The WaveForm A interbody seamlessly integrates with the company...

OFIX - Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the presentation of multiple clinical and scientific abstracts during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in San Francisco June 1-3, 2023. ...

OFIX - Orthofix Medical Inc. (OFIX) Q1 2023 Earnings Call Transcript

2023-05-14 08:04:10 ET Orthofix Medical Inc. (OFIX) Q1 2023 Results Conference Call May 09, 2023 04:30 PM ET Company Participants Alexa Huerta - Senior Director, Investor Relations Keith Valentine - President and Chief Executive Officer John Bostjancic - Chief Fi...

OFIX - Orthofix Non-GAAP EPS of -$0.10 beats by $0.10, revenue of $175.2M beats by $6.74M

2023-05-09 16:49:11 ET Orthofix press release ( NASDAQ: OFIX ): Q1 Non-GAAP EPS of -$0.10 beats by $0.10 . Revenue of $175.2M (+64.7% Y/Y) beats by $6.74M . For further details see: Orthofix Non-GAAP EPS of -$0.10 beats by $0.10, revenue of $175.2M beats ...

OFIX - Orthofix Reports First Quarter 2023 Results

Net sales of $175.2 million, an increase of 65% on a reported basis and 12% on a pro forma constant currency basis over prior year Bone Growth Therapies growth of 14%, with growth coming from both spine and fracture commercial channels U.S. spinal implant sales up 18% over...

OFIX - MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the STIM onTrack ™ mobile app was recognized as the “Best Patient Engagement Mobile App” by MedTech Breakthrough, an independent market intelligence organization t...

OFIX - Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2023 financial results on Tuesday, May 9, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the ...

OFIX - Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures. The Lattus ™ Lateral Access System and the Fathom ...

OFIX - Orthofix Announces More Than 5,000 Fitbone Intramedullary Limb-lengthening Devices Implanted Worldwide to Date and Over Twenty Years of Clinical History

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced Fitbone ™ TAA intramedullary limb-lengthening system has passed 5,000 devices implanted to date with more than 20 years of clinical history demonstrating safety and effectiveness...

Previous 10 Next 10